MAM
LNAI

Meeder Asset Management’s Lunai Bioworks LNAI Stock Holding History

Meeder Asset Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7
Closed -$3K – 2071
2021
Q3 		$3K Hold
7
– – ﹤0.01% 2100
2021
Q2 		$3K Hold
7
– – ﹤0.01% 2127
2021
Q1 		$1K Buy
+7
New +$2.06K ﹤0.01% 2251
2020
Q4 		– Sell
-8
Closed -$1K – 2150
2020
Q3 		$1K Hold
8
– – ﹤0.01% 2033
2020
Q2 		$2K Hold
8
– – ﹤0.01% 1796
2020
Q1 		$1K Hold
8
– – ﹤0.01% 2221
2019
Q4 		$2K Buy
+8
New +$3.52K ﹤0.01% 2047

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Meeder Asset Management's LNAI Position: Q4 2021 in Review

Meeder Asset Management sold out of Lunai Bioworks (LNAI) in Q4 2021, closing a stake of 7 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in LNAI in Q4 2019 and held it in 7 quarters. The position peaked at $3K in Q3 2021. 44 funds tracked by Wall St. Rank hold LNAI as of Q4 2021.

  • Meeder Asset Management reported no remaining Lunai Bioworks position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 7 Lunai Bioworks shares in Q4 2021, an estimated $3K.
  • Meeder Asset Management first reported a position in Lunai Bioworks in Q4 2019 and held it in 7 quarters.
  • Meeder Asset Management's Lunai Bioworks position peaked at $3K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.